
Japanese child idol Hirata Runa dies at age 8 from influenza complications
Nagoya-based singer and DIANNA Project member Hirata Runa died on 25 September following acute myocarditis caused by influenza, her agency and family confirmed.
Sudden passing in Nagoya
Japanese child singer Hirata Runa, who performed under the stage name Luna-Chan, died in hospital on Friday, 25 September, at approximately 04:00 in the morning. She was eight years old at the time of her passing. The performer suffered from acute myocarditis, an inflammation of the heart muscle tissue that arose as a rapid complication following an influenza infection. Official statements from her representatives described the condition as an uncommon yet potentially lethal viral complication that restricts the heart's capacity to pump blood normally. Her agency and relatives confirmed that the illness developed with rapid severity while she was under hospital care, leading to her peaceful passing in the early morning hours. The announcement of her death was withheld from the public until early October, allowing her immediate family to conduct private funeral ceremonies without outside disruption.
Final stage appearance and idol career
Born in April 2018 in the Japanese city of Nagoya, situated midway between Tokyo and Kyoto, Hirata joined the entertainment industry at an early age. She trained in vocal performance and choreography as a member of the Nagoya-based DIANNA Project. In Japan, idol groups recruit young performers through talent agencies to cultivate stage skills and build close emotional connections with audiences. Hirata spent one-third of her life active as an idol within the group. Her sudden hospitalization occurred only five days after she delivered a live stage performance before an audience. After stepping off the stage at that final concert, she posed for photographs and published a brief message to express her appreciation to attending fans.
Thank you for today as well, I appreciated it very much. It was really fun.
- Hirata Runa is born in Nagoya, Japan
- Performs in her final live concert and posts a message to fans
- Dies at 04:00 in hospital from myocarditis caused by influenza
- DIANNA Project publicly announces her death after private funeral services
Agency and family response
Following the completion of the private memorial services, DIANNA Project released an official statement confirming the circumstances surrounding the artist's passing. The talent management group expressed gratitude to the audience who had supported Hirata throughout her artistic activities. The agency also requested that supporters and media outlets respect the family's bereavement by avoiding unsolicited inquiries, interview requests, and social media questioning.
We extend our deepest gratitude to all the fans who supported Hirata Runa and to everyone involved who provided assistance. In consideration of the feelings of the bereaved family, we kindly ask that you refrain from making individual inquiries, requesting interviews, or posting questions on social media regarding this matter.
In an accompanying message, Hirata's family expressed grief over the sudden loss and honored her dedication to music and public performance. Her relatives noted that she loved everyone and spent one-third of her life as an idol, asking supporters to keep her memory as an eternal idol in a corner of their hearts.
Medical complications from influenza
Myocarditis is clinically defined as an inflammation of the muscular tissue of the heart, known as the myocardium. This condition impairs the heart's ability to contract effectively, diminishing blood circulation throughout the body and posing severe risks. Although influenza is primarily recognized as a common viral respiratory infection, secondary viral spread to cardiac tissue can provoke acute inflammatory responses. Medical evaluations note that such viral complications are rare but can progress with rapid severity in pediatric patients compared to adults. In young children, rapid onset of cardiac inflammation can result in severe cardiac dysfunction before clinical interventions can stabilize the patient.


